23andMe, the pioneering genetic testing company, announced this week it has entered voluntary Chapter 11 bankruptcy proceedings as part of a restructuring and sale process. The company, which has served over 15 million customers worldwide since its founding in 2006, will continue normal operations while seeking a buyer.
In an open letter to customers dated March 23, 2025, the company emphasized that user data remains protected and account access will continue unchanged during the transition. "Our users' privacy and data are important considerations in any transaction, and we remain committed to our users' privacy," the company stated.
The Chapter 11 filing allows 23andMe to continue operating while pursuing potential buyers through a court-supervised auction. The company indicated it is seeking a partner "who shares our commitment to customer data privacy and allows our mission of helping people access, understand and benefit from the human genome to live on."
Customers can still purchase DNA testing kits and access their genetic reports as before, though the company has modified its refund policy. New purchases will now have a 24-hour window for refund requests, while purchases made before March 23 maintain the standard 30-day refund period.
The bankruptcy proceedings automatically pause ongoing litigation against the company, including class action lawsuits. 23andMe has established a dedicated restructuring website and customer care team to address questions during this process.
